Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Moderau N, Poyia F, Schwartzberg LS, Tabassum N, Wen J, Krell J, Stebbing J.

Oncotarget. 2018 Feb 24;9(25):17589-17596. doi: 10.18632/oncotarget.24564. eCollection 2018 Apr 3.

2.

Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Herzog T, Levitan J, Moderau N, Schwartzberg L, Tabassum N, Wen J, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15166. doi: 10.18632/oncotarget.24691. eCollection 2018 Mar 13.

3.

Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.

Carter P, Alifrangis C, Chandrasinghe P, Cereser B, Del Bel Belluz L, Leo CA, Moderau N, Tabassum N, Warusavitarne J, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15165. doi: 10.18632/oncotarget.24690. eCollection 2018 Mar 13.

4.

Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2018 Mar 13;9(19):15164. doi: 10.18632/oncotarget.24689. eCollection 2018 Mar 13.

5.

The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.

Carter P, Alifrangis C, Chandrasinghe P, Cereser B, Del Bel Belluz L, Leo CA, Moderau N, Tabassum N, Warusavitarne J, Krell J, Stebbing J.

Oncotarget. 2018 Jan 16;9(13):11371-11376. doi: 10.18632/oncotarget.24257. eCollection 2018 Feb 16. Erratum in: Oncotarget. 2018 Mar 13;9(19):15165.

6.

Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J.

Oncotarget. 2017 Dec 27;9(5):6007-6014. doi: 10.18632/oncotarget.23675. eCollection 2018 Jan 19. Erratum in: Oncotarget. 2018 Mar 13;9(19):15164.

7.

The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection.

Del Bel Belluz L, Guidi R, Pateras IS, Levi L, Mihaljevic B, Rouf SF, Wrande M, Candela M, Turroni S, Nastasi C, Consolandi C, Peano C, Tebaldi T, Viero G, Gorgoulis VG, Krejsgaard T, Rhen M, Frisan T.

PLoS Pathog. 2016 Apr 7;12(4):e1005528. doi: 10.1371/journal.ppat.1005528. eCollection 2016 Apr.

8.

Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.

Pivetta E, Wassermann B, Del Bel Belluz L, Danussi C, Modica TM, Maiorani O, Bosisio G, Boccardo F, Canzonieri V, Colombatti A, Spessotto P.

Clin Sci (Lond). 2016 Jul 1;130(14):1221-36. doi: 10.1042/CS20160064. Epub 2016 Feb 26.

9.

Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1.

Pivetta E, Danussi C, Wassermann B, Modica TM, Del Bel Belluz L, Canzonieri V, Colombatti A, Spessotto P.

Matrix Biol. 2014 Feb;34:22-32. doi: 10.1016/j.matbio.2014.01.018. Epub 2014 Feb 7.

PMID:
24513040
10.

Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43).

Romano M, Buratti E, Romano G, Klima R, Del Bel Belluz L, Stuani C, Baralle F, Feiguin F.

J Biol Chem. 2014 Mar 7;289(10):7121-30. doi: 10.1074/jbc.M114.548859. Epub 2014 Feb 3.

11.

EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance.

Danussi C, Del Bel Belluz L, Pivetta E, Modica TM, Muro A, Wassermann B, Doliana R, Sabatelli P, Colombatti A, Spessotto P.

Mol Cell Biol. 2013 Nov;33(22):4381-94. doi: 10.1128/MCB.00872-13. Epub 2013 Sep 9.

12.

An EMILIN1-negative microenvironment promotes tumor cell proliferation and lymph node invasion.

Danussi C, Petrucco A, Wassermann B, Modica TM, Pivetta E, Del Bel Belluz L, Colombatti A, Spessotto P.

Cancer Prev Res (Phila). 2012 Sep;5(9):1131-43. doi: 10.1158/1940-6207.CAPR-12-0076-T. Epub 2012 Jul 24.

13.

EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation.

Danussi C, Petrucco A, Wassermann B, Pivetta E, Modica TM, Del Bel Belluz L, Colombatti A, Spessotto P.

J Cell Biol. 2011 Oct 3;195(1):131-45. doi: 10.1083/jcb.201008013. Epub 2011 Sep 26.

Supplemental Content

Loading ...
Support Center